Program coverage through the Amgen SupportPlus Co-Pay Card is contingent on (1) the submission of the required Explanation of Benefits (EOB) form within 180 days of the date of approval documented on the EOB for medical benefit claims or (2) the submission of the claim within 180 days of the date of service for pharmacy benefit claims.
ENBREL COPAY CARD PHONE NUMBER FULL
(See PROGRAM DETAILS section in the full Terms & Conditions.) Please ask your Amgen SupportPlus Support Representative to help you understand eligibility for the Amgen SupportPlus Co-Pay Card by calling (866) 264-2778.
Patients are responsible for all amounts that exceed this limit. $25 out-of-pocket for each dose of Prolia® or EVENITY®Īmgen will pay the remaining eligible out-of-pocket costs on behalf of the patient until the Amgen payments have reached either the Maximum Program Benefit and/or the Patient Total Program Benefit.$0 out-of-pocket for each dose or cycle of the Amgen SupportPlus product (excluding Prolia® and EVENITY®).Amgen SupportPlus patients may pay as little as:.(See PROGRAM BENEFITS section in the full Terms & Conditions.) Please ask your Amgen SupportPlus Support Representative to help you understand eligibility for the Amgen SupportPlus Co-Pay Card, whether your particular insurance coverage is likely to result in your reaching the Maximum Program Benefit or your Patient Total Program Benefit amount by calling (866) 264-2778. Whether you are eligible to receive the Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. If a patient's commercial insurance plan imposes different or additional requirements on patients who receive Amgen SupportPlus Co-Pay Card benefits, Amgen has the right to modify or eliminate those benefits. The Amgen SupportPlus Co-Pay Card provides support up to the Maximum Program Benefit or Patient Total Program Benefit. The Amgen SupportPlus Co-Pay Card does not cover any other costs related to office visits or administration of the product. Out-of-pocket costs may include co-payment, co-insurance, and deductible out-of-pocket costs. The Amgen SupportPlus Co-Pay Card may help lower your Amgen SupportPlus product out-of-pocket medication costs.(See ELIGIBILITY section in the full Terms & Conditions.) It is not valid for cash paying patients or where prohibited by law. The program is not valid for patients whose prescription for an Amgen SupportPlus product is paid for in whole or in part by Medicare, Medicaid, or any other federal or state healthcare program.
The Amgen SupportPlus Co-Pay Card is open to patients with commercial insurance that covers an Amgen SupportPlus product listed above, regardless of financial need.These terms and conditions apply to the following products:īLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec), KANJINTI® (trastuzumab-anns), KYPROLIS® (carfilzomib), LUMAKRAS® (sotorasib), MVASI® (bevacizumab-awwb), NEULASTA® (pegfilgrastim), NEUPOGEN® (filgrastim), NPLATE® (romiplostim), PROLIA® (denosumab), RIABNI™ (rituximab-arrx), VECTIBIX® (panitumumab), XGEVA® (denosumab), EVENITY® (romosozumab-aqqg), and AVSOLA® (infliximab-axxq) The following summary is not a substitute for reviewing the Terms and Conditions in their entirety. It is important that every patient read and understand the full Amgen SupportPlus Co-Pay Card Terms and Conditions. Amgen® SupportPlus Co-Pay Card Terms and Conditions
0 kommentar(er)
